SURG

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 10.58 M11.52 M18.68 M16.19 M15.98 M16.2 M 67.06 M Gross profit -2.94 M-2.65 M-2.6 M-2.4 M-7.7 M-425.17 K -13.11 M Operating expenses 4.64 M4.16 M4.35 M6.92 M3.5 M319.1 K 15.1 M Selling/general/admin expenses 4.64 M4.16 M4.35 M6.92 M3.5 M4.63 M 19.41 M Research & development —————— — Operating income -7.58 M-6.81 M-6.95 M-12.8 M-11.2 M3.45 M -27.49 M Non-Operating Income, Total -55.39 K-272.3 K-539.16 K-1.07 M-851.67 K-2.16 M -4.62 M Interest expense, net of interest capitalized 238.87 K212.42 K424.67 K1.25 M881.91 K1.03 M 3.58 M Non-Operating Income, excl. Interest Expenses -55.39 K-272.3 K-964.18 K-2.31 M-1.73 M-3.21 M -8.22 M Unusual income/expense 7 140-3553550020.29 K 20.64 K Pretax income -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M1.29 M -32.11 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest -209-209-227-193-151-227 -798 After tax other income/expense —————— — Net income before discontinued operations -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M1.29 M -32.11 M Discontinued operations 0————— — Net income -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M1.29 M -32.11 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M1.29 M -32.11 M Basic earnings per share (Basic EPS) -0.38-0.36-0.38-0.68-0.510.05 -1.52 Diluted earnings per share (Diluted EPS) -0.38-0.36-0.38-0.68-0.510.05 -1.52 Average basic shares outstanding 20.07 M19.89 M19.84 M20.09 M23.7 M25.92 M — Diluted shares outstanding 20.07 M19.89 M19.84 M20.09 M23.7 M25.92 M — EBITDA -7.49 M-6.74 M-6.92 M-12.77 M-11.17 M-5.03 M -35.9 M EBIT -7.58 M-6.81 M-6.95 M-12.8 M-11.2 M-5.06 M -36.01 M Cost of revenue 13.52 M14.17 M21.28 M18.58 M23.68 M16.63 M 80.17 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 86.12 K66.36 K26.84 K26.84 K26.84 K26.84 K 107.35 K